Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04143516 · ClinicalTrials.gov registry record · Phase 2
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
A Phase 2 study of Liver Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04143516 is a Phase 2 study of Liver Metastases that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 200 participants, above the 61-participant average among 27 other Liver Metastases trials with a reported enrollment target (228% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04143516, a Phase 2 study of Liver Metastases, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identify cancer cells that are still alive. The results of these biopsies could help determine the next treatment for your cancer, but the biopsies could cause side effects.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST PET/CT Scan
- DIAGNOSTIC_TEST [18-F]- FDG - PET
- PROCEDURE Tumor ablation (TA)
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04143516
The ClinicalTrials.gov registry entry for NCT04143516 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 27 other Liver Metastases trials with a reported enrollment target (228% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Metastases appearing as the primary indexed condition, and to 3 interventions - of which PET/CT Scan is the first listed.
NCT04143516 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04143516 about?
NCT04143516 is a clinical study titled "Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment". This study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identify cancer cells that are still alive. The results of these biopsies could help determine the next treatment for your cancer, but the biopsies...
What is the current status of trial NCT04143516?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2019-10-25. Estimated completion is 2026-10.
What conditions does trial NCT04143516 study?
This clinical trial studies the following conditions: Liver Metastases.
What interventions are being tested in trial NCT04143516?
The interventions under investigation include: PET/CT Scan (DIAGNOSTIC_TEST), [18-F]- FDG - PET (DIAGNOSTIC_TEST), Tumor ablation (TA) (PROCEDURE).
Who is sponsoring clinical trial NCT04143516?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04143516 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
RECRUITING · Phase 2
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
RECRUITING · Phase 2
-
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
RECRUITING · Phase 2
-
ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
RECRUITING · Phase 2
-
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.